HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.90
-0.47 (-3.27%)
Sep 24, 2026, 4:00 PM EDT - Market closed
HUTCHMED (China) Employees
HUTCHMED (China) had 1,790 employees as of June 30, 2026.
Employees
1,790
Change
n/a
Growth
n/a
Revenue / Employee
$306,772
Profits / Employee
$9,991
Market Cap
2.41B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,790 | - | - |
| Dec 31, 2025 | 1,796 | -15 | -0.83% |
| Dec 31, 2024 | 1,811 | -177 | -8.90% |
| Dec 31, 2023 | 1,988 | -37 | -1.83% |
| Dec 31, 2022 | 2,025 | 265 | 15.06% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Alvotech | 1,279 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
HCM News
- 1 day ago - HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026 - GlobeNewsWire
- 3 days ago - Hutchmed price target raised to $18 from $16 at BofA - TheFly
- 14 days ago - HUTCHMED (China) Ltd (HCM) Stock Down 3.2% -- Now Undervalued? GF Score: 81/100 - GuruFocus
- 16 days ago - Hutchmed upgraded to Buy from Hold at HSBC - TheFly
- 21 days ago - HUTCHMED Lands GSK Deal Worth Up to $1.3B for KRAS-EGFR Cancer Therapy - MarketBeat
- 21 days ago - Hutchmed upgraded to Buy from Hold at Daiwa - TheFly
- 21 days ago - Hutchmed rises 13.7% - TheFly
- 21 days ago - HUTCHMED Stock (HCM) Rallies Over 15% on a Major Licensing Deal - TipRanks